Manama: The Royal Medical Services announced that a sickle cell patient has been discharged from the hospital after successfully completing treatment through a bone marrow transplant using CRISPR gene-editing technology. He is the first sickle cell patient outside the US to be publicly announced as having received the treatment successfully.
According to Bahrain News Agency, Brigadier General Dr. Shaikh Fahad bin Khalifa Al Khalifa, Commander of the Royal Medical Services, stated that this medical achievement by the Bahrain Oncology Centre reflects Bahrain's progress in offering advanced treatments. He credited this success to the vision and directives of His Majesty King Hamad bin Isa Al Khalifa and the ongoing support of His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister.
He further mentioned that the Royal Medical Services is dedicated to providing the latest treatments and enhancing cooperation with international health institutions and organizations to maintain the highest standards of healthcare for all citizens and residents.
The patient conveyed gratitude to His Majesty the King, HRH the Crown Prince and Prime Minister, and the medical team at the Royal Medical Services for their care and support during his treatment. He emphasized Bahrain's advanced medical care and healthcare facilities, acknowledging their pivotal role in his successful recovery.
He also referred to the visit of HRH the Crown Prince and Prime Minister as a significant gesture that underscored Bahrain's commitment to prioritizing the well-being of its people. He expressed appreciation for the Kingdom's leadership and shared hopes for Bahrain's continued advancement.